Wednesday, July 8, 2026

Patent intelligence · US

US 9056046

Standardized extract and its use in the manufacture of a medicament

granted A61KA61K31/57A61K31/575A61K36/42
Status granted
Linked drugs 1
Pipeline programs 6
Years to expiry 9
Applicant portfolio 39
Patent details — US 9056046
Jurisdiction
US
Status
granted
Grant date
Jun 16, 2015
Expiration
Jun 11, 2035
Claims
20
CPC classes
A61K, A61K31/57, A61K31/575, A61K36/42
View on Google Patents ↗

Quick answer

US 9056046 (Standardized extract and its use in the manufacture of a medicament) is held by Botanic Century (Beijing) Co. Ltd.. Status: granted. Granted Jun 16, 2015. Expires Jun 11, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
20
CPC classes
A61K, A61K31/57, A61K31/575, A61K36/42, A61K9/0031, A61K9/02

More from Botanic Century (Beijing) Co. Ltd.

Related pharmaceutical patents in our USPTO index.

  1. US 12274710

    Compound for regulating body weight imbalance, composition thereof and application thereof

    GUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD · Expires Apr 10, 2045

    granted
  2. US 12269888

    Artificial cell death polypeptide for chimeric antigen receptor and uses thereof

    Century Therapeutics, Inc. · Expires Apr 3, 2045

    granted
  3. US 12194049

    Composition for treating carbapenem antibiotic-resistant Acinetobacter baumannii infection

    GUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD · Expires Jan 9, 2045

    granted
  4. US 12084670

    Regulating alkaloids

    22ND CENTURY LIMITED, LLC · Expires Sep 5, 2044

    granted
  5. US 11883432

    Chimeric antigen receptor system with adaptable receptor specificity

    Century Therapeutics, Inc. · Expires Jan 25, 2044

    granted
  6. US 11865155

    Plant extract obtained from Morus plant leaves which has an IC50 value to inhibit a-glucosidase I at a concentration of less than 90 uG/ml, compositions containing same, method of extraction and uses thereof

    Botanic Century (Beijing) Co. Ltd. · Expires Jan 4, 2044

    granted
  7. US 11667924

    Increasing levels of nicotinic alkaloids in plants

    22ND CENTURY LIMITED, LLC · Expires Jun 1, 2043

    granted
  8. US 11661459

    Artificial cell death polypeptide for chimeric antigen receptor and uses thereof

    Century Therapeutics, Inc. · Expires May 25, 2043

    granted

Frequently asked questions

What is US patent 9056046?

US 9056046 (Standardized extract and its use in the manufacture of a medicament) is held by Botanic Century (Beijing) Co. Ltd.. Status: granted. Granted Jun 16, 2015. Expires Jun 11, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 9056046?

Botanic Century (Beijing) Co. Ltd. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 39 pharmaceutical patents for this assignee.

When does US 9056046 expire?

Our index shows an expiration date of Jun 11, 2035 (9 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.